Global Drug of Abuse (DOA) Testing Consumables Market Research Report 2021
Table of Contents1 Drug of Abuse (DOA) Testing Consumables Market Overview
1.1 Product Overview and Scope of Drug of Abuse (DOA) Testing Consumables
1.2 Drug of Abuse (DOA) Testing Consumables Segment by Type
1.2.1 Global Drug of Abuse (DOA) Testing Consumables Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Rapid Test Kits
1.2.3 Assay Kits and Reagents
1.2.4 Others
1.3 Drug of Abuse (DOA) Testing Consumables Segment by Application
1.3.1 Drug of Abuse (DOA) Testing Consumables Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Workplace
1.3.5 At-Home
1.3.6 Others
1.4 Global Drug of Abuse (DOA) Testing Consumables Market Size Estimates and Forecasts
1.4.1 Global Drug of Abuse (DOA) Testing Consumables Revenue 2016-2027
1.4.2 Global Drug of Abuse (DOA) Testing Consumables Sales 2016-2027
1.4.3 Drug of Abuse (DOA) Testing Consumables Market Size by Region: 2016 Versus 2021 Versus 2027
2 Drug of Abuse (DOA) Testing Consumables Market Competition by Manufacturers
2.1 Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Manufacturers (2016-2021)
2.2 Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Drug of Abuse (DOA) Testing Consumables Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Drug of Abuse (DOA) Testing Consumables Manufacturing Sites, Area Served, Product Type
2.5 Drug of Abuse (DOA) Testing Consumables Market Competitive Situation and Trends
2.5.1 Drug of Abuse (DOA) Testing Consumables Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Drug of Abuse (DOA) Testing Consumables Players Market Share by Revenue
2.5.3 Global Drug of Abuse (DOA) Testing Consumables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug of Abuse (DOA) Testing Consumables Retrospective Market Scenario by Region
3.1 Global Drug of Abuse (DOA) Testing Consumables Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Drug of Abuse (DOA) Testing Consumables Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Drug of Abuse (DOA) Testing Consumables Market Facts & Figures by Country
3.3.1 North America Drug of Abuse (DOA) Testing Consumables Sales by Country
3.3.2 North America Drug of Abuse (DOA) Testing Consumables Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Drug of Abuse (DOA) Testing Consumables Market Facts & Figures by Country
3.4.1 Europe Drug of Abuse (DOA) Testing Consumables Sales by Country
3.4.2 Europe Drug of Abuse (DOA) Testing Consumables Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Drug of Abuse (DOA) Testing Consumables Market Facts & Figures by Region
3.5.1 Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales by Region
3.5.2 Asia Pacific Drug of Abuse (DOA) Testing Consumables Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Drug of Abuse (DOA) Testing Consumables Market Facts & Figures by Country
3.6.1 Latin America Drug of Abuse (DOA) Testing Consumables Sales by Country
3.6.2 Latin America Drug of Abuse (DOA) Testing Consumables Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Drug of Abuse (DOA) Testing Consumables Market Facts & Figures by Country
3.7.1 Middle East and Africa Drug of Abuse (DOA) Testing Consumables Sales by Country
3.7.2 Middle East and Africa Drug of Abuse (DOA) Testing Consumables Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Drug of Abuse (DOA) Testing Consumables Historic Market Analysis by Type
4.1 Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2016-2021)
4.2 Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Type (2016-2021)
4.3 Global Drug of Abuse (DOA) Testing Consumables Price by Type (2016-2021)
5 Global Drug of Abuse (DOA) Testing Consumables Historic Market Analysis by Application
5.1 Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2016-2021)
5.2 Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Application (2016-2021)
5.3 Global Drug of Abuse (DOA) Testing Consumables Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Siemens AG
6.1.1 Siemens AG Corporation Information
6.1.2 Siemens AG Description and Business Overview
6.1.3 Siemens AG Drug of Abuse (DOA) Testing Consumables Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Siemens AG Product Portfolio
6.1.5 Siemens AG Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Drug of Abuse (DOA) Testing Consumables Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Drug of Abuse (DOA) Testing Consumables Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Roche Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Corporation Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Thermo Fisher Scientific Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Bio-Rad
6.5.1 Bio-Rad Corporation Information
6.5.2 Bio-Rad Description and Business Overview
6.5.3 Bio-Rad Drug of Abuse (DOA) Testing Consumables Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bio-Rad Product Portfolio
6.5.5 Bio-Rad Recent Developments/Updates
6.6 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Drug of Abuse (DOA) Testing Consumables Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Abbott Product Portfolio
6.6.5 Abbott Recent Developments/Updates
6.7 Quest Diagnostics
6.6.1 Quest Diagnostics Corporation Information
6.6.2 Quest Diagnostics Description and Business Overview
6.6.3 Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Quest Diagnostics Product Portfolio
6.7.5 Quest Diagnostics Recent Developments/Updates
6.8 Psychemedics
6.8.1 Psychemedics Corporation Information
6.8.2 Psychemedics Description and Business Overview
6.8.3 Psychemedics Drug of Abuse (DOA) Testing Consumables Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Psychemedics Product Portfolio
6.8.5 Psychemedics Recent Developments/Updates
7 Drug of Abuse (DOA) Testing Consumables Manufacturing Cost Analysis
7.1 Drug of Abuse (DOA) Testing Consumables Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Drug of Abuse (DOA) Testing Consumables
7.4 Drug of Abuse (DOA) Testing Consumables Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Drug of Abuse (DOA) Testing Consumables Distributors List
8.3 Drug of Abuse (DOA) Testing Consumables Customers
9 Drug of Abuse (DOA) Testing Consumables Market Dynamics
9.1 Drug of Abuse (DOA) Testing Consumables Industry Trends
9.2 Drug of Abuse (DOA) Testing Consumables Growth Drivers
9.3 Drug of Abuse (DOA) Testing Consumables Market Challenges
9.4 Drug of Abuse (DOA) Testing Consumables Market Restraints
10 Global Market Forecast
10.1 Drug of Abuse (DOA) Testing Consumables Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Drug of Abuse (DOA) Testing Consumables by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Drug of Abuse (DOA) Testing Consumables by Type (2022-2027)
10.2 Drug of Abuse (DOA) Testing Consumables Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Drug of Abuse (DOA) Testing Consumables by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Drug of Abuse (DOA) Testing Consumables by Application (2022-2027)
10.3 Drug of Abuse (DOA) Testing Consumables Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Drug of Abuse (DOA) Testing Consumables by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Drug of Abuse (DOA) Testing Consumables by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global Drug of Abuse (DOA) Testing Consumables Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Drug of Abuse (DOA) Testing Consumables Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Drug of Abuse (DOA) Testing Consumables Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Drug of Abuse (DOA) Testing Consumables Covered in This Study
Table 5. Global Drug of Abuse (DOA) Testing Consumables Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Drug of Abuse (DOA) Testing Consumables Sales Share by Manufacturers (2016-2021)
Table 7. Global Drug of Abuse (DOA) Testing Consumables Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Drug of Abuse (DOA) Testing Consumables Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Drug of Abuse (DOA) Testing Consumables Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Drug of Abuse (DOA) Testing Consumables Manufacturing Sites and Area Served
Table 11. Manufacturers Drug of Abuse (DOA) Testing Consumables Product Type
Table 12. Global Drug of Abuse (DOA) Testing Consumables Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Drug of Abuse (DOA) Testing Consumables by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug of Abuse (DOA) Testing Consumables as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Drug of Abuse (DOA) Testing Consumables Sales by Region (2016-2021) & (K Units)
Table 16. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Region (2016-2021)
Table 17. Global Drug of Abuse (DOA) Testing Consumables Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Drug of Abuse (DOA) Testing Consumables Sales by Country (2016-2021) & (K Units)
Table 19. North America Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country (2016-2021)
Table 20. North America Drug of Abuse (DOA) Testing Consumables Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country (2016-2021)
Table 22. Europe Drug of Abuse (DOA) Testing Consumables Sales by Country (2016-2021) & (K Units)
Table 23. Europe Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country (2016-2021)
Table 24. Europe Drug of Abuse (DOA) Testing Consumables Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Drug of Abuse (DOA) Testing Consumables Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Drug of Abuse (DOA) Testing Consumables Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Region (2016-2021)
Table 30. Latin America Drug of Abuse (DOA) Testing Consumables Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country (2016-2021)
Table 32. Latin America Drug of Abuse (DOA) Testing Consumables Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country (2016-2021)
Table 38. Global Drug of Abuse (DOA) Testing Consumables Sales (K Units) by Type (2016-2021)
Table 39. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2016-2021)
Table 40. Global Drug of Abuse (DOA) Testing Consumables Revenue (Million US$) by Type (2016-2021)
Table 41. Global Drug of Abuse (DOA) Testing Consumables Revenue Share by Type (2016-2021)
Table 42. Global Drug of Abuse (DOA) Testing Consumables Price (USD/Unit) by Type (2016-2021)
Table 43. Global Drug of Abuse (DOA) Testing Consumables Sales (K Units) by Application (2016-2021)
Table 44. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2016-2021)
Table 45. Global Drug of Abuse (DOA) Testing Consumables Revenue (Million US$) by Application (2016-2021)
Table 46. Global Drug of Abuse (DOA) Testing Consumables Revenue Share by Application (2016-2021)
Table 47. Global Drug of Abuse (DOA) Testing Consumables Price (USD/Unit) by Application (2016-2021)
Table 48. Siemens AG Corporation Information
Table 49. Siemens AG Description and Business Overview
Table 50. Siemens AG Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Siemens AG Drug of Abuse (DOA) Testing Consumables Product
Table 52. Siemens AG Recent Developments/Updates
Table 53. Merck Corporation Information
Table 54. Merck Description and Business Overview
Table 55. Merck Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Merck Drug of Abuse (DOA) Testing Consumables Product
Table 57. Merck Recent Developments/Updates
Table 58. Roche Corporation Information
Table 59. Roche Description and Business Overview
Table 60. Roche Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Roche Drug of Abuse (DOA) Testing Consumables Product
Table 62. Roche Recent Developments/Updates
Table 63. Thermo Fisher Scientific Corporation Information
Table 64. Thermo Fisher Scientific Description and Business Overview
Table 65. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Product
Table 67. Thermo Fisher Scientific Recent Developments/Updates
Table 68. Bio-Rad Corporation Information
Table 69. Bio-Rad Description and Business Overview
Table 70. Bio-Rad Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Bio-Rad Drug of Abuse (DOA) Testing Consumables Product
Table 72. Bio-Rad Recent Developments/Updates
Table 73. Abbott Corporation Information
Table 74. Abbott Description and Business Overview
Table 75. Abbott Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Abbott Drug of Abuse (DOA) Testing Consumables Product
Table 77. Abbott Recent Developments/Updates
Table 78. Quest Diagnostics Corporation Information
Table 79. Quest Diagnostics Description and Business Overview
Table 80. Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Product
Table 82. Quest Diagnostics Recent Developments/Updates
Table 83. Psychemedics Corporation Information
Table 84. Psychemedics Description and Business Overview
Table 85. Psychemedics Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Psychemedics Drug of Abuse (DOA) Testing Consumables Product
Table 87. Psychemedics Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Drug of Abuse (DOA) Testing Consumables Distributors List
Table 91. Drug of Abuse (DOA) Testing Consumables Customers List
Table 92. Drug of Abuse (DOA) Testing Consumables Market Trends
Table 93. Drug of Abuse (DOA) Testing Consumables Growth Drivers
Table 94. Drug of Abuse (DOA) Testing Consumables Market Restraints
Table 95. Global Drug of Abuse (DOA) Testing Consumables Sales Forecast by Type (2022-2027) & (K Units)
Table 96. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Drug of Abuse (DOA) Testing Consumables Sales Forecast by Application (2022-2027) & (K Units)
Table 100. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Drug of Abuse (DOA) Testing Consumables Sales Forecast by Region (2022-2027) & (K Units)
Table 104. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of FiguresFigure 1. Product Picture of Drug of Abuse (DOA) Testing Consumables
Figure 2. Global Drug of Abuse (DOA) Testing Consumables Market Share by Type in 2020 & 2027
Figure 3. Rapid Test Kits Product Picture
Figure 4. Assay Kits and Reagents Product Picture
Figure 5. Others Product Picture
Figure 6. Global Drug of Abuse (DOA) Testing Consumables Market Share by Application in 2020 & 2027
Figure 7. Hospitals
Figure 8. Laboratories
Figure 9. Workplace
Figure 10. At-Home
Figure 11. Others
Figure 12. Global Drug of Abuse (DOA) Testing Consumables Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Drug of Abuse (DOA) Testing Consumables Market Size 2016-2027 (US$ Million)
Figure 14. Global Drug of Abuse (DOA) Testing Consumables Sales 2016-2027 (K Units)
Figure 15. Global Drug of Abuse (DOA) Testing Consumables Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Drug of Abuse (DOA) Testing Consumables Sales Share by Manufacturers in 2020
Figure 17. Global Drug of Abuse (DOA) Testing Consumables Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Drug of Abuse (DOA) Testing Consumables Players: Market Share by Revenue in 2020
Figure 19. Drug of Abuse (DOA) Testing Consumables Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Region (2016-2021)
Figure 21. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Region in 2020
Figure 22. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Region (2016-2021)
Figure 23. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Region in 2020
Figure 24. U.S. Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Drug of Abuse (DOA) Testing Consumables by Type (2016-2021)
Figure 49. Sales Market Share of Drug of Abuse (DOA) Testing Consumables by Application (2016-2021)
Figure 50. Sales Market Share of Drug of Abuse (DOA) Testing Consumables by Application in 2020
Figure 51. Revenue Share of Drug of Abuse (DOA) Testing Consumables by Application (2016-2021)
Figure 52. Revenue Share of Drug of Abuse (DOA) Testing Consumables by Application in 2020
Figure 53. Manufacturing Cost Structure of Drug of Abuse (DOA) Testing Consumables
Figure 54. Manufacturing Process Analysis of Drug of Abuse (DOA) Testing Consumables
Figure 55. Drug of Abuse (DOA) Testing Consumables Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed